In terms of further study on the topic, a mention should be made of the evidence for which 10% of colorectal cancer patients carry BRAF V600E and BRAF-related mutations, whose event is associated with a worse prognosis and poor outcomes towards systemic therapies. This evidence concerns the gene BRAF and colorectal cancer.